# Patient satisfaction with a chronic kidney disease risk assessment service in community pharmacies

Gheewala, PA, Peterson, GM ORCID: 0000-0002-6764-3882, Razi Zaidi, ST ORCID: 0000-0002-2031-1055, Jose, MD ORCID: 0000-0002-9589-0071 and Castelino, RL 2018 , 'Patient satisfaction with a chronic kidney disease risk assessment service in community pharmacies' , International journal of clinical pharmacy , doi: 10.1007/s11096-018-0603-2.

Full text not available from this repository.

## Abstract

Background: Patient satisfaction is an important determinant of the feasibility and sustainability of community pharmacyscreening services. However, few studies have evaluated this, with no such study performed for a chronic kidney diseaserisk assessment service.Objective: The aim was to determine patient satisfaction with a chronic kidney disease risk assessment service performedin community pharmacies.Setting: Community pharmacies in the state of Tasmania, Australia.Method: An anonymous nine-item satisfaction survey, with Likert-type scales, was developed following a literature review ofexisting surveys. Reliability of the nine-item scale was determined using Cronbach’s alpha. Patients were asked an additionalquestion on willingness to pay, with choices of amount from $5 to$25. The satisfaction survey was mailed to 389 patientswho participated in the chronic kidney disease risk assessment study.Main outcome measure: Patient level of satisfaction with and willingness to pay for the chronic kidney disease service.Results: Responses from 143 participants were included in the fnal analysis. Cronbach’s alpha for the nine-item satisfactionscale was 0.87. The majority of participants agreed that the time required to undergo the risk assessment process wasjustifed (90.2%); overall, they were satisfed with the chronic kidney disease risk assessment service (90.0%) and they feltcomfortable with the pharmacist referring their results to their doctor (88.9%). Of 136 participants who answered the questionon willingness to pay, 62.9% indicated that they would pay for the chronic kidney disease service. Of these, 29.2, 25.8and 19.1% were willing to pay $20,$10 and \$5, respectively.Conclusion: Patient satisfaction with the community pharmacy-based chronic kidney disease risk assessment was high. Thesefndings provide support for the implementation of the service within community pharmacy practice.

Item Type: Article Gheewala, PA and Peterson, GM and Razi Zaidi, ST and Jose, MD and Castelino, RL kidney disease pharmacist International journal of clinical pharmacy Springer 2210-7703 10.1007/s11096-018-0603-2 Copyright 2018 Springer International Publishing AG, part of Springer Nature View statistics for this item